Tyra Biosciences Inc

TYRA remains in a Stage 2 advancing corrective reset within a broader secular uptrend, marked by a Lockout Rally continuation pattern and rising EMAs. Price has reclaimed and is now pulling back into the 9/20 EMA band above the rising 50 DMA, with no overbought or exhaustion signals evident. Medium- and short-term biases are bullish, presenting favorable conditions to buy now on pullbacks into the EMA structure.

• ↑10.23% weekly gain to $33.02 reflects strong price momentum
• ↑High institutional interest via robust 13F holdings signals confidence
• ↓Negative earnings yield signals potential value-trap risk